Blair William & CO Crispr Therapeutics Ag Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Blair William & CO holds 121,909 shares of CRSP stock, worth $4.94 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

121,909

Previous 134,969 9.68%

Holding current value

$4.94 Million

Previous $7.29 Million 21.42%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$44.62 - $62.75 $582,737 - $819,515	-13,060 Reduced 9.68%	121,909 $5.73 Million
Q2 2024 Aug 12, 2024	SELL	$51.17 - $68.18 $661,167 - $880,953	-12,921 Reduced 8.74%	134,969 $7.29 Million
Q1 2024 May 09, 2024	BUY	$60.67 - $89.12 $678,897 - $997,252	11,190 Added 8.19%	147,890 $10.1 Million
Q4 2023 Feb 12, 2024	BUY	$38.62 - $72.18 $147,296 - $275,294	3,814 Added 2.87%	136,700 $8.56 Million
Q3 2023 Nov 09, 2023	BUY	$45.39 - $59.0 $45 - $59	1 Added 0.0%	132,886 $6.03 Million
Q2 2023 Aug 11, 2023	BUY	$43.47 - $67.77 $159,534 - $248,715	3,670 Added 2.84%	132,885 $7.46 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $2.03 Million - $2.78 Million	49,622 Added 62.34%	129,215 $5.84 Million
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $121,410 - $203,445	-3,098 Reduced 3.75%	79,593 $3.24 Million
Q3 2022 Nov 09, 2022	BUY	$61.1 - $83.78 $138,024 - $189,259	2,259 Added 2.81%	82,691 $5.4 Million
Q2 2022 Aug 10, 2022	SELL	$43.23 - $73.83 $1.47 Million - $2.5 Million	-33,892 Reduced 29.65%	80,432 $4.89 Million
Q1 2022 May 13, 2022	BUY	$53.19 - $79.24 $1.19 Million - $1.77 Million	22,302 Added 24.24%	114,324 $7.18 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $196,181 - $311,500	-2,799 Reduced 2.95%	92,022 $6.97 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $792,558 - $1.13 Million	7,192 Added 8.21%	94,821 $10.6 Million
Q2 2021 Aug 12, 2021	BUY	$100.84 - $161.89 $721,711 - $1.16 Million	7,157 Added 8.89%	87,629 $14.2 Million
Q1 2021 May 13, 2021	BUY	$110.72 - $210.04 $1.07 Million - $2.02 Million	9,637 Added 13.6%	80,472 $9.81 Million
Q4 2020 Feb 09, 2021	BUY	$79.67 - $173.23 $93,930 - $204,238	1,179 Added 1.69%	70,835 $10.8 Million
Q3 2020 Nov 06, 2020	BUY	$78.5 - $100.64 $267,920 - $343,484	3,413 Added 5.15%	69,656 $5.83 Million
Q2 2020 Aug 12, 2020	SELL	$38.5 - $76.05 $35,035 - $69,205	-910 Reduced 1.36%	66,243 $4.87 Million
Q1 2020 May 11, 2020	SELL	$33.68 - $62.53 $115,354 - $214,165	-3,425 Reduced 4.85%	67,153 $2.85 Million
Q4 2019 Feb 13, 2020	BUY	$36.68 - $73.13 $400,839 - $799,164	10,928 Added 18.32%	70,578 $4.3 Million
Q3 2019 Nov 12, 2019	SELL	$40.99 - $52.56 $77,881 - $99,864	-1,900 Reduced 3.09%	59,650 $2.45 Million
Q2 2019 Aug 13, 2019	BUY	$35.45 - $48.2 $1.64 Million - $2.23 Million	46,315 Added 304.0%	61,550 $2.9 Million
Q1 2019 May 14, 2019	BUY	$28.02 - $40.87 $2,802 - $4,086	100 Added 0.66%	15,235 $544,000
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $27,276 - $50,808	1,200 Added 8.61%	15,135 $432,000
Q3 2018 Nov 13, 2018	SELL	$44.35 - $65.71 $78,189 - $115,846	-1,763 Reduced 11.23%	13,935 $618,000
Q2 2018 Aug 13, 2018	BUY	$42.62 - $73.59 $8,438 - $14,570	198 Added 1.28%	15,698 $922,000
Q1 2018 May 15, 2018	BUY	$23.52 - $58.17 $364,560 - $901,635	15,500 New	15,500 $709,000
Q4 2017 Feb 14, 2018	SELL	$16.95 - $23.48 $262,725 - $363,940	-15,500 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$16.75 - $20.66 $259,625 - $320,230	15,500	15,500 $277,000

Others Institutions Holding CRSP

# of Institutions

489

Shares Held

57.9M

Call Options Held

1.09M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.16B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account